A small VC group ex­pands its hunt for in­spired biotech founders in need of seed cash

Civ­i­liza­tion Ven­tures, a Cal­i­for­nia-based VC fund that suc­cess­ful­ly bet on biotechs Rock­et Phar­ma­ceu­ti­cals and Sin­gu­lar Bio a few years ago, is bring­ing forth its next round of in­vest­ments.

Found­ed by en­tre­pre­neur Shahram Seyedin-Noor, the com­pa­ny has closed a $35 mil­lion fundraise and an­nounced Tues­day morn­ing it plans to in­vest in three ar­eas: di­ag­nos­tics, syn­thet­ic bi­ol­o­gy and AI-re­lat­ed dig­i­tal health. The new life sci­ences cap­i­tal comes three years af­ter Civ­i­liza­tion’s first fund, an $8 mil­lion pool that saw Rock­et go pub­lic through re­verse merg­er and Sin­gu­lar be ac­quired by med­ical-ge­net­ics com­pa­ny In­vi­tae.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER